Benzo[c]quinolizin-3-ones: A Novel Class of Potent and Selective Nonsteroidal Inhibitors of Human Steroid 5α-Reductase 1

    September 2000 in “ Journal of Medicinal Chemistry
    Antonio Guarna, Fabrizio Machetti, Ernesto G. Occhiato, Dina Scarpi, Alessandra Comerci, Giovanna Danza, Rosa Mancina, Mario Serio, K. G. Hardy
    Image of study
    TLDR Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.
    The study focused on the stereochemical assignments of benzo[c]quinolizin-3-ones, a novel class of nonsteroidal inhibitors of human steroid 5α-reductase 1. The researchers used semi-empirical AMI studies and ¹H NMR spectroscopy to determine the relative stereochemistry of these compounds. They found that the nitrogen atom in these compounds exhibited an intermediate hybridization between sp² and sp³, influencing the chair-like conformation of the A ring. The stereochemistry of various methyl-substituted derivatives was assigned based on coupling constant values and chemical shifts observed in the NMR spectra. The findings provided insights into the structural characteristics necessary for the inhibitory activity of these compounds.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 14 results

    Similar Research

    5 / 296 results
      Novel Inhibitors of 5α-Reductase

      research Novel Inhibitors of 5α-Reductase

      20 citations, February 2002 in “Expert Opinion on Therapeutic Patents”
      New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.
      Clinical Application of 5α-Reductase Inhibitors

      research Clinical Application of 5α-Reductase Inhibitors

      46 citations, March 2001 in “Journal of endocrinological investigation”
      5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

      research Pathobiology of Androgenetic Alopecia

      5 citations, November 2003 in “Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc Czech Republic”
      The exact causes of baldness are not fully understood, limiting treatment options.
      5α-Reductase Inhibitors: Chemical and Clinical Models

      research 5α-Reductase Inhibitors: Chemical and Clinical Models

      17 citations, May 1998 in “Steroids”
      Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.